AIM ImmunoTech, Inc. (AIM)

1.21 -0.05 (-3.97%) USD  |  NYAM  |  Jan 23, 12:45
More

AIM ImmunoTech Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade